N-(2-Hydroxypropyl)methacrylamide - Moligand™, 10 mM in DMSO , CAS No.21442-01-3

CAS: 21442-01-3 Cat. No.: N1500800 Summenformel: C₇H₁₃NO₂ Molekulargewicht: 143.19 EG-Nummer: 801-057-1

GRADE & PURITY Moligand™, 10 mM in DMSO

Storage

Argon charged,Store at -80°C

Shipped In

Dry ice packs + Cold packs

Übersicht

N-(2-Hydroxypropyl)methacrylamide is used to synthesize copolymers for the targeted delivery of antileishmanial agents in Visceral leishmaniasis (VL) .

Specifications

Spezifikationen & Reinheit

Moligand™, 10 mM in DMSO

Storage

Argon charged,Store at -80°C

Verschickt in

Dry ice packs + Cold packs

Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.

Note

Moligand™

Namen und Kennungen

• Isomere SMILES: CC(CNC(=O)C(=C)C)O
• Molekulargewicht: 143.19
• Reaxy-Rn: 2074155
• Reaxys-RN_link_address: https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=2074155&ln=

Chemische und physikalische Eigenschaften

• Schmelzpunkt (°C): 70 °C

Referenzen

1. Qingqing Yang, Yang Yang, Lian Li, Wei Sun, Xi Zhu, Yuan Huang.  (2015)  Polymeric Nanomedicine for Tumor-Targeted Combination Therapy to Elicit Synergistic Genotoxicity against Prostate Cancer.  ACS Applied Materials & Interfaces,      [PMID:25775367] [10.1021/am509204u]

2. Changyong Guo, Shipeng He, Huaxing Shen, Wei Cong, Jinqiu Li, Yajing Ji, Wenjing Huang, Fei Gao, Honggang Hu.  (2025)  Polymer-assisted PD-L1 degradation and targeted photodynamic therapy synergize to suppress immunodeficient tumors.  Acta Pharmaceutica Sinica B,      [PMID:40698133] [10.1016/j.apsb.2025.05.022]